H ypoxic pulmonary vasoconstriction (HPV) is the rapid, reversible increase in pulmonary vascular resistance that occurs when the alveolar oxygen tension falls below a threshold level. In conditions characterized by segmental alveolar hypoxia (e.g., single-lung anesthesia, atelectasis, or pneumonia), HPV is restricted to the segments of the vasculature serving the hypoxic lobe, thereby achieving ventilation/perfusion matching and optimizing systemic PO 2 without significantly elevating pulmonary artery (PA) pressure. During global hypoxia, as occurs in the normal fetus, or after birth, with ascent to altitude or hypoventilation syndromes, HPV is involved in the initiation and/or maintenance of pulmonary hypertension (PHT). HPV is found in virtually all mammals, although populations and species truly adapted to life at high altitude (Tibetan natives, yaks, etc.) have diminished or absent HPV, an adaptation that allows them to avoid PHT while living in their rarefied environment. The importance of understanding HPV extends beyond its role in pathophysiology; its mechanism has relevance to O 2 sensing in other cardiovascular tissues, including the ductus arteriosus, the type 1 cell of the carotid body, the adrenomedullary cells, and the neuroepithelial body.
Properties of HPV
There are certain cardinal features of HPV that must be accounted for by any proposed mechanism.
HPV is intrinsic to resistance PAs. HPV occurs in isolated lungs, small PA rings, and even in isolated PA smooth muscle cells (SMCs; Fig. 1 ). HPV is strongest in small muscular PAs (>3rd generation). Although most segments of the pulmonary circulation, including pulmonary veins, constrict in response to hypoxia, proximal PAs dilate (3) .
HPV onsets and resolves rapidly. HPV onsets within 1 min of exposure to hypoxia, is sustained during hypoxia, and rapidly reverses on return to normoxia (Fig. 1A) .
HPV is triggered by hypoxia, not anoxia. Because of the unique location of resistance PAs, near the terminal airways and alveoli, they preferentially respond to alveolar rather than intravascular PO 2 . In humans, HPV onsets with inspired O 2 concentrations J12%. In vivo, HPV is uniphasic, a plateau pressure being attained within minutes that is not increased by repeated challenges or altered when hypoxic ventilation is sus-tained for hours. This is also true in isolated lungs perfused with blood; however, HPV increases with repeated challenges when Krebs-albumin perfusate is used.
Although HPV is modulated by numerous mediators, its core mechanism is independent of endothelial and neurohumoral factors. Although the core mechanism of HPV is postulated to reside within PA SMCs, the magnitude of HPV is modulated by circulating mediators and the autonomic nervous system. HPV is diminished by inhibitors of the endothelin, leukotriene, or serotonin pathways and is enhanced by inhibitors of prostaglandin or nitric oxide synthesis. To date, it seems that none of these mediators is essential to HPV (for review, see Ref. 8) .
Dependence on extracellular Ca
2+
. HPV is inhibited by antagonists (Fig. 1C) and enhanced by agonists of the voltagedependent, L-type Ca 2+ channel (e.g., BAY K 8644; for review, see Ref. 8) . Although this suggests that HPV is dependent on the influx of extracellular Ca 2+ , there is debate as to the relative contribution of release of intracellular Ca 2+ vs. Ca 2+ influx through the L-type Ca 2+ channel. However, most of the reports suggesting a major role for Ca 2+ release derive from studies of isolated arteries in which pretreatment with a vasoconstrictor, which might itself trigger release of Ca 2+ , has been used to "prime" HPV.
Hypoxia inhibits whole cell K
+ current in PA but not systemic arterial SMCs. Interestingly, hypoxia dilates systemic arteries (Fig. 1A) and either increases or fails to inhibit K + current (I K ) in systemic arterial SMCs (for review, see Ref. 8) . However, 4-aminopyridine (4-AP) inhibits I K in SMC from both PA and renal arteries. The opposing hypoxic responses of the PA vs. systemic arteries may result either from tissue-specific differences in the O 2 sensor or in the response of the K + channels to a common redox mediator.
O 2 -sensitive Kv channels: the effector mechanism of HPV
HPV is initiated, at least in part, by the inhibition of a family of O 2 -sensitive Kv channels leading to membrane depolarization, opening of the L-type Ca 2+ channel, and vasoconstriction ( Fig. 1, AC) . The activity of the L-type Ca 2+ channel is largely regulated by membrane potential (E M ), which is established by K + channels. The more Kv inhibition occurs, the more depolarized the PA SMC, and the more opening of the L-type channels (a pathway leading to influx of extracellular Ca 2+ ). As predicted by this hypothesis (Fig. 1G) , Ca 2+ channel blockers substantially reduce HPV (Fig. 1C) There has recently been significant progress in establishing the molecular identity of the O 2 -sensitive K + channels involved in HPV. This task is difficult because the I K is an ensemble of current conducted through many channel types. However, comparing the pharmacology of the O 2 -sensitive K + current (I KvO2 ) with that of clonal K + channels in expression systems has been useful in suggesting candidate O 2 -sensitive channels. I KvO2 in PA SMCs is slowly inactivating, 4-AP sensitive, and resistant to charybdotoxin (8) . This profile tends to exclude a role for 4-AP-insensitive channels (i.e., BK Ca ), rapidly inactivating channels (e.g., Kv1.4 and Kv4.3), and charybdotoxin-sensitive channels (e.g., homotetrameric Kv1.2 and Kv1.6 channels). Furthermore, Kv1.2 homotetramers have a current morphology (slowly activating with run-up on repeat stimulation) quite distinct from that seen in PA SMCs and are exquisitely sensitive to charybdotoxin, suggesting that the role of Kv1.2 in HPV is most likely through its involvement in charybdotoxininsensitive heterotetramers with Kv1.5 (for review, see Ref. 8). Kv2.1, alone or in combination with Kv9.2 ,-subunits, also has a pharmacological profile and O 2 sensitivity consistent with a role in HPV.
Several groups have proposed that multiple Kv channels are involved in HPV, including homo-and heterotetramers comprised of Kv1.2, Kv1.5, Kv2.1, and Kv3.1b (for review, see Ref. 8) . To identify which of the clonal Kv channels accounts for HPV, we developed an immunoelectropharmacological approach to identifying the channels involved in creating the O 2 -sensitive I K mosaic. This approach utilized the specificity of anti-Kv channel antibodies to functionally inhibit Kv current in PA SMCs from resistance PAs. Introduction of anti-Kv2.1 or anti-Kv1.5 (but not anti-inward rectifier K + channel antibodies) via the patch pipette technique inhibits a portion of I K and partially depolarizes E M (reviewed in Ref. 7). Kv1.5 is an appealing candidate for involvement in HPV because it is 4-AP sensitive and charybdotoxin insensitive. Furthermore, in rodents exposed to chronic hypoxia, acute HPV is selectively suppressed, whereas response to other vasoconstrictors is preserved. Loss of acute HPV persists for several days after return to normoxia and is associated with decreased Kv1.5 expression in cultured PA SMCs (18) and in vivo (data from our laboratory show reduced Kv1.5 and Kv2.1). Kv1.5 expression is also reduced in other forms of PHT. In addition, anorexigens, such as dexfenfluramine, that cause vasoconstriction and outbreaks of PHT inhibit I K (others have shown that they directly block both Kv1.5 and Kv2.1). Because pharmacological and immunologic probes lack the specificity to distinguish the contribution of candidate channels to I K , we examined the effects of targeted deletion of Kv1.5 in mice. The Kv1.5 knockout mouse displays reduced HPV ( cascade (the mitochondrial ETC) that accompanies normal metabolism creates a small flux of signaling molecules (AOS). Both AOS generation and ETC function occur in proportion to PO 2 . These AOS can exit the mitochondria and alter the reduction/oxidation status of specific, sulfhydryl-rich amino acids in key enzymes and proteins (notably Kv channels). Reduction or oxidation can thus alter channel function and link PO 2 to vascular tone.
Redox potential is a measure of the relative tendency of a substance to acquire or donate electrons. In the case of mitochondrial ETC, electrons flow from electron donors, NADH and FADH, to distal electron recipients because of the dinucleotide's more negative reduction-oxidation potential. The more negative this potential, the more likely a substance is to donate an electron. In the mitochondrial ETC, electrons flow down a potential gradient of redox potential ranging from 0.35 for NADH/NAD + to +0.82 for O 2 /H 2 O. Physiological generation of AOS occurs during normal electron shuttling by cytochromes within the ETC. Although most of the O 2 used by the mitochondrial ETC is eventually reduced to H 2 O, ~2% is incompletely reduced, due to single electron reductions, and yields AOS, particularly the superoxide radical.
AOS were originally thought to be too toxic to serve a physiological role, but like nitric oxide, in low amounts these species are important signaling molecules. Although AOS can be produced by xanthine oxidase, cyclooxygenase, and nitric oxide synthase, the PO 2 -responsive production of AOS primarily occurs in the mitochondrial ETC and several vascular oxidases, including NAD(P)H and novel vascular oxidases (NOX). Both the mitochondrial ETC and vascular oxidases generate the superoxide radical. Superoxide radical is very unstable, AOS can regulate the function of target proteins by donating electrons to highly negatively charged residues. Reduction or oxidation of the sulfhydryl groups of amino acids, such as cysteine or methionine, may cause conformational changes in the K + channel that change channel gating and open probability. A number of other important signaling substances such as kinases and phosphatases are now also known to be redox sensitive. Therefore, AOS, whether diffusing out of mitochondria or produced by membrane-bound oxidases, can affect target proteins that control vascular tone, including Kv channels. Because the production of AOS changes rapidly in response to changes in ambient O 2 within the physiological range (Fig.  3D) , these molecules are attractive mediator candidates for the mechanism of HPV.
The redox theory of HPV proposes that there is a tonic, basal production of AOS in the PA vascular SMCs, most likely generated within the mitochondria. It is also conceivable that NADPH oxidase contributes to the normoxic production of radicals. This "normal" rate of generation of AOS causes a physiological level of oxidation of the K + channels in PA SMCs. We postulate that normoxic oxidation causes K + channel activation and a more negative E M , thereby inactivating the L-type Ca 2+ channel and promoting the low resting tone observed in the pulmonary circulation. In this hypothesis, AOS are a signal for "normoxic vasodilatation" (Fig. 4) . The concept that AOS can serve as physiological signals, rather than mediators of toxic injury, was controversial when it was initially proposed (1) and perhaps still is. Under conditions of alveolar hypoxia, production of AOS falls in proportion to the inspired O 2 concentration (F i O 2 ). The PA SMCs respond to the withdrawal of the tonic oxidant signal with redox inhibition of K + channels (Fig. 4) .
The data supporting this "redox hypothesis" can be summarized briefly as follows. First, AOS are formed in the lung and PAs in proportion to the ambient PO 2 . Second, inhibitors of the proximal mitochondrial ETC, such as rotenone and antimycin A, mimic hypoxia. Both hypoxia and mitochondrial ETC inhibitors reduce the production of AOS in the lung, inhibit Kv current, and elicit pulmonary vasoconstriction (Fig. 3D) (2) . Furthermore, unlike other drug classes, including distal ETC inhibitors, proximal ETC inhibitors (such as rotenone and antimycin A) cause PA constriction (2), carotid body activation, and the relaxation of systemic arteries and the ductus arteriosus (unpublished data; see Ref. 8 for review). Although it is tempting to explain hypoxia and metabolic inhibitor-induced pulmonary vasoconstriction on the basis of the ability of these stimuli to eventually cause ATP depletion, Buescher et al. (see Ref. 8) used nuclear magnetic resonance spectroscopy to show that ATP is preserved in isolated lungs during moderate hypoxia. Teleologically, the role of the lung as a net supplier, rather than a consumer, of O 2 (in marked contrast to all other organs) may explain the unique occurrence of hypoxiainduced vasoconstriction in PAs. A third line of support for the redox theory is that AOS alter I K and vascular tone much as O 2 does. There are several means by which changes in PO 2 might alter the function of ion channels. In the simplest scenario, hypoxia could directly inhibit the K + channel by a redox mechanism. Certainly, some (but not all) K + channels can be directly (i.e., in excised patches) opened or closed by redox modulation in vitro (see Ref. 8 for review). Reducing agents, such as GSH, NADH, and dithionite, inhibit K + channels in PA SMCs, whereas oxidants, such as diamide or GSSG, activate K + channels (see Ref. 8 for review) . However, the concept of a redox-sensitive K + channel is also essential to hypotheses that place the O 2 sensor at a distance from the Kv channel (i.e., in the mitochondrial ETC or NADPH oxidase). In both the mitochondrial and membrane oxidase sensor models, a freely diffusible electron donor or AOS, such as H 2 O 2 , signals the change in PO 2 and initiates a redox modulation of the K + channel (Fig. 4) . However, this signal, by definition, requires a receptive or "redox-sensitive" Kv channel.
It is also possible that redox sensitivity may be conferred to Kv channels by coassociation of Kv ,-subunits with --subunits, smaller subunits that have significant homology to the NADPH oxidoreductases. Three --subunit genes (Kv-1.1, Kv-2, and Kv-3) are expressed in PA SMC. Although they can increase inactivation of Kv1.x channels or shift the activation of channels toward more negative potentials, their role in HPV is unknown. Hulme et al. (see Ref. 8) found that Kv1.2, -1.5, and -2.1/9.3 are O 2 sensitive even when expressed in expression systems, presumably without --subunits. Another means by which Kv channels may become more O 2 sensitive relates to the association between functional Kv channel ,-subunits and electrically nonconducting ,-subunits in families Kv59. Kv5 9 homotetramers do not conduct current; however, when associated with functional Kv channel proteins, they form heterotetramers with altered activation and inactivation properties, which may be important in conferring O 2 sensitivity (e.g., the Kv2.1/9.3; see Ref. 6) .
Mitochondria as O 2 sensors. Inhibitors of the mitochondrial ETC mimic hypoxia's effects on the carotid body (e.g., increase sinus nerve activity) and PA (cause vasoconstriction; Fig. 3 ). Both hypoxia and mitochondrial ETC inhibitors reduce the production of AOS in the lung, inhibit a Kv current (2), and elicit pulmonary vasoconstriction (Fig. 3D) . As early as 1986, a link was proposed between mitochondrial AOS production, cellular redox status, K + currents, and HPV (1). Subsequently, it was confirmed that inhibitors of complex I and III, but not complex IV, cause pulmonary vasoconstriction, inhibit I K , and prevent further HPV, suggesting the existence of a mitochondrial O 2 sensor (2). The mitochondria generate a superoxide anion at complexes I and III that is dismutated by mitochondrial-specific MnSOD, generating the diffusible signaling molecule H 2 O 2 . Recently, another group (19) has offered supportive evidence for the role of mitochondria, with findings indicating that mitochondria complex III is important in HPV. They showed that proximal ETC blockers suppressed HPV without affecting the response to other vasoconstrictors. Their conclusions, implicating the proximal ETC in oxygen sensing, are in agreement with our hypothesis. However, they found that AOS were increased by hypoxia and ETC inhibition, whereas others found that, in the pulmonary circulation, hypoxia decreases AOS (5, 10, 14) . This discrepancy may relate to the fluorescent probe they used to measure AOS, which is sensitive to nitric oxide and can itself generate AOS (see below). Inhibition of ETC function not only decreases the production of AOS but also shifts the ratio of cytosolic redox couples, such as NADH/NAD and GSH/GSSG, to a more reduced ratio (15) . This "backup" of reduced substances in the cytosol occurs rapidly and at a physiologically relevant range of PO 2 (15) . Thus when mitochondrial electron shuttling is diminished by hypoxia, there is both less AOS production and an accumulation of the reduced form of several electron donors in the cytosol. Either or both of these interrelated redox changes could also serve an O 2 sensor function.
NADPH oxidase. NADPH oxidase, another putative source of signaling AOS for HPV, is a flavocytochrome present in phagocytes, carotid body type 1 cells, neuroepithelial bodies, PA SMCs, and endothelial cells. It includes a membranebound flavocytochrome containing two subunits, gp91phox and p22phox, and the cytosolic proteins p47phox and p67phox, which bind to the flavocytochrome to form the active enzyme complex (Fig. 3, AC, and Fig. 4) (5) . The NADPH oxidase uses both flavin and heme groups to shuttle electrons from NADPH to oxygen, yielding superoxide radical. NADPH oxidase produces AOS in proportion to PO 2 and has been touted as a possible redox O 2 sensor (14) . Both NADPH and NADH oxidase, named according to their substrate preference, are present in PA SMCs. AOS formation by the NADH isoform decreases as PO 2 falls and is inhibited by diphenyleneiodonium (DPI; see Ref. 8 for review). These are features consistent with the oxidase acting as a redox O 2 sensor. Although DPI inhibits I K , it causes minimal vasoconstriction and inhibits HPV (see Ref. 8 for review) . However, the lack of a greater constrictor effect may be because DPI is also a Ltype Ca 2+ channel blocker (see Ref. 8 for review). Unfortunately, DPI nonspecifically inhibits flavoprotein-containing enzymes, including NADPH oxidases, nitric oxide synthase, and complex I of the mitochondrial ETC (see Ref. 8 for review). Thus DPI is a poor tool for assessing the physiological role of NADPH oxidase in regulating vascular tone. The development of mice deficient in NADPH oxidase activity due to mutation of the X-linked gene for gp91phox provided an opportunity to study the role of NAD(P)H oxidase in HPV. Most O 2 -responsive cell types contain a similar form of the oxidase, containing the gp91phox component. HPV is preserved in mice lacking a functional gp91phox despite a marked reduction in AOS production in their lungs (Fig. 3, AC) (5) . This suggests that NADPH oxidases containing gp91phox are not required for HPV (5) . Moreover, rotenone constriction is enhanced in these mice, consistent with the mitochondrial O 2 sensor hypothesis (5). Preserved O 2 sensing has also been reported in the type 1 cell of the carotid body from gp91phox knockout mice, although the O 2 sensing is impaired in their neuroepithelial bodies.
Controversies
Controversies related to models and experimental methodologies. Many of the controversies in the field relate to the use of models that do not display the fundamental characteristics of HPV. Another cause of confusion is the substitution of anoxia or chemical hypoxia (e.g., that induced by dithionite) for authentic hypoxia. Unfortunately, papers using these suboptimal models or hypoxia surrogates often refer to the phenomenon studied as "HPV" and the stimulus as "hypoxia," overlooking the intrinsic dissimilarities between the model and HPV in vivo. For example, proximal PAs dilate to hypoxia, and after a brief constriction anoxia causes pulmonary vasodilatation; finally, dithionite does not elicit HPV in vivo. Another cause for diversity in findings among laboratories studying HPV is the failure to uniformly adhere to the tight pH and temperature standards when studying HPV. HPV is largely absent at room temperature and is diminished by severe alkalosis. Finally, models that only display HPV when primed should be viewed with caution; priming is not required in vivo or in isolated lungs. An even more insidious cause of confusion is failure to define whether one is studying one of the myriad pathways that modulate the magnitude of HPV or its core mechanism.
Controversies regarding the molecular identity of the redox sensor. Vascular SMCs contain gp91phox homologs, called NOX, which also preferentially use NADPH as a substrate. NOXs are inhibited by DPI and are important sources of AOS in systemic vascular SMCs (11) . However, most studies of NOX have been performed in systemic arteries and have measured AOS production in response to vasoconstrictors (e.g., angiotensin II) or mitogens (e.g., platelet-derived growth factor). There is little evidence that NOX are involved AOS pro-"The NAPDH oxidase uses both flavin and heme groups to shuttle electrons from NADPH to oxygen, yielding superoxide radical." duction in PA SMC. It is noteworthy that angiotensin II does not cause an acute change in AOS production in mouse lungs at doses that cause vasoconstriction (5) . Perhaps the predominant source of AOS differs between PAs, in which AOS may be signaling molecules serving to optimize O 2 uptake from the environment, vs. systemic arteries, in which AOS may be involved in the pathogenesis of atherosclerosis (which is rare in PAs).
Effects of hypoxia and ETC inhibitors on PA SMC AOS production. There is debate as to whether hypoxia and ETC inhibitors decrease (2, 5) or increase (19) production of AOS. As discussed in the section on mitochondrial O 2 sensors, much of the controversy results from the use of 2',7'-dichlorodihydrofluorescein diacetate (DCF), an agent that preferentially detects nitric oxide (as mentioned in the product insert) and that can itself increase generation of one of the species it is often used to detect, namely H 2 O 2 (16). Rota et al. (16) studied DCF by using several techniques, including electron spin resonance, and concluded that "DCF cannot be used conclusively to measure superoxide or hydrogen peroxide formation in cells undergoing oxidative stress."
Controversy regarding endothelin and the mechanism of HPV. In rats, the endothelin (ET) A -receptor antagonist BQ-123, but not the ET B -receptor antagonist BQ-788, inhibits HPV. However, the K ATP antagonist glibenclamide prevents BQ-123 inhibition of HPV. Thus ET-1 reinforces HPV by suppressing compensatory, vasodilator K ATP channel activity (17) and also can inhibit Kv current via a protein kinase C-dependent mechanism. Although endothelin's role in HPV remains unclear, it may be an important mechanism in reinforcing the hypoxic response.
Conclusion
We propose the following model for O 2 sensing. In normoxia, the proximal mitochondrial ETC produces AOS, some of which (such as H 2 O 2 ) can diffuse to the plasmalemma, oxidizing and thus opening K + channels. This favors normoxic membrane hyperpolarization and vasodilatation. Hypoxia is sensed in the proximal ETC, and perhaps vascular oxidases, resulting in a decrease in AOS production. Decrease in AOS levels and the associated increases in reducing equivalents in the cytoplasm promote a reduced state that causes K + channel inhibition, membrane depolarization, and vasoconstriction.
